Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 273 No 7306 p20
3 July 2004

This article
Reprint   Photocopy

PDF 100K, Acrobat Reader

Letters

· Pharmacy education
· Big Conversation
· Electronic prescribing
· Advertising
· Statins
· Free movement in Europe
· St John's wort
· The profession
· The Journal


Letters to the Editor

Electronic prescribing

Electronic prescribing must be introduced for the right reasons

From Mr A. Barker, MRPharmS

Lord Warner’s announcement (PJ, 19 June, p755) that the introduction of hospital electronic prescribing is being brought forward to 2006 should be welcomed. However, the rationale for this decision appears to be a little suspect. Although electronic prescribing will deliver the ability to conduct prospective audit, and feedback, on the use of National Institute for Clinical Excellence recommended medicines, this should not be a prime reason for its introduction.

There is no doubt that electronic prescribing will make a major contribution to increasing patient safety and the quality of clinical care and, if it is to achieve the level of clinician support that will be required for successful implementation, these must be the reasons for its introduction.

Already our own limited experience of implementing electronic prescribing has resulted in improvements in the quality of prescribing, with approaching 10 per cent of prescribing transactions being modified by the provision of online decision support. However, the improvements we have seen have not been restricted to prescribing. Electronic clinical pharmacist verification and administration recording, together with full integration with pharmacy stock control, have led to significant improvements in the safety, quality and efficiency of other medicines-related activities.

We must guard against any acceleration of the development of electronic prescribing resulting in loss of potential major advantages that a more prolonged gestation period may provide. My concern is that if the focus of the development is on “mechanisms to allow prospective audit and feedback on usage of drugs” we may well end up with little more than electronic “order communications” for medicines, with many of the potential improvements in patient safety and the quality of clinical care that could be offered by a fully integrated prescribing administration and medicines management system being lost along the way.

After all, reasonable information on the use of NICE recommended medicines can already be provided by existing hospital pharmacy computer systems and any shortfall in uptake of NICE recommendations is more likely to be due to lack of resources than lack of information.

Andrew Barker
Clinical Director — Pharmacy and Medicines Management
Doncaster & Bassetlaw Hospitals NHS Foundation Trust

Send your letter to The Editor

Previous Topic (Big Conversation)
Next Topic (Advertising)

Back to Top


©The Pharmaceutical Journal